vs
Side-by-side financial comparison of Agilent Technologies (A) and SOMNIGROUP INTERNATIONAL INC. (SGI). Click either name above to swap in a different company.
SOMNIGROUP INTERNATIONAL INC. is the larger business by last-quarter revenue ($1.9B vs $1.8B, roughly 1.0× Agilent Technologies). Agilent Technologies runs the higher net margin — 17.0% vs 7.5%, a 9.4% gap on every dollar of revenue. On growth, SOMNIGROUP INTERNATIONAL INC. posted the faster year-over-year revenue change (54.7% vs 7.0%). Agilent Technologies produced more free cash flow last quarter ($175.0M vs $41.1M). Over the past eight quarters, SOMNIGROUP INTERNATIONAL INC.'s revenue compounded faster (25.3% CAGR vs 6.9%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
Somnigroup International Inc. is an American manufacturer of mattresses and bedding products.
A vs SGI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $1.9B |
| Net Profit | $305.0M | $140.8M |
| Gross Margin | 52.6% | 44.0% |
| Operating Margin | 19.6% | 13.2% |
| Net Margin | 17.0% | 7.5% |
| Revenue YoY | 7.0% | 54.7% |
| Net Profit YoY | -4.1% | 95.8% |
| EPS (diluted) | $1.07 | $0.71 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | $1.9B | ||
| Q3 25 | $1.7B | $2.1B | ||
| Q2 25 | $1.7B | $1.9B | ||
| Q1 25 | $1.7B | $1.6B | ||
| Q4 24 | $1.7B | $1.2B | ||
| Q3 24 | $1.6B | $1.3B | ||
| Q2 24 | $1.6B | $1.2B |
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | $140.8M | ||
| Q3 25 | $336.0M | $177.4M | ||
| Q2 25 | $215.0M | $99.0M | ||
| Q1 25 | $318.0M | $-33.1M | ||
| Q4 24 | $351.0M | $71.9M | ||
| Q3 24 | $282.0M | $130.0M | ||
| Q2 24 | $308.0M | $106.1M |
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | 44.0% | ||
| Q3 25 | 51.1% | 44.9% | ||
| Q2 25 | 51.9% | 44.0% | ||
| Q1 25 | 53.5% | 36.2% | ||
| Q4 24 | 53.9% | 43.3% | ||
| Q3 24 | 54.2% | 45.4% | ||
| Q2 24 | 54.4% | 44.9% |
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | 13.2% | ||
| Q3 25 | 20.7% | 14.8% | ||
| Q2 25 | 18.0% | 9.6% | ||
| Q1 25 | 22.4% | 0.8% | ||
| Q4 24 | 24.0% | 10.6% | ||
| Q3 24 | 21.1% | 15.5% | ||
| Q2 24 | 23.1% | 14.0% |
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | 7.5% | ||
| Q3 25 | 19.3% | 8.4% | ||
| Q2 25 | 12.9% | 5.3% | ||
| Q1 25 | 18.9% | -2.1% | ||
| Q4 24 | 20.6% | 6.0% | ||
| Q3 24 | 17.9% | 10.0% | ||
| Q2 24 | 19.6% | 8.6% |
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $0.71 | ||
| Q3 25 | $1.18 | $0.83 | ||
| Q2 25 | $0.75 | $0.47 | ||
| Q1 25 | $1.11 | $-0.17 | ||
| Q4 24 | $1.23 | $0.40 | ||
| Q3 24 | $0.97 | $0.73 | ||
| Q2 24 | $1.05 | $0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | — |
| Total DebtLower is stronger | $3.0B | $4.6B |
| Stockholders' EquityBook value | $6.9B | $3.1B |
| Total Assets | $12.8B | $11.6B |
| Debt / EquityLower = less leverage | 0.44× | 1.47× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.8B | — | ||
| Q2 24 | $1.7B | — |
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $4.6B | ||
| Q3 25 | $3.4B | $4.5B | ||
| Q2 25 | $3.3B | $4.8B | ||
| Q1 25 | $3.3B | $4.9B | ||
| Q4 24 | $3.3B | $3.7B | ||
| Q3 24 | $2.1B | $2.2B | ||
| Q2 24 | $2.1B | $2.4B |
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $3.1B | ||
| Q3 25 | $6.4B | $3.0B | ||
| Q2 25 | $6.1B | $2.8B | ||
| Q1 25 | $6.0B | $2.7B | ||
| Q4 24 | $5.9B | $559.0M | ||
| Q3 24 | $5.9B | $564.5M | ||
| Q2 24 | $6.2B | $411.8M |
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | $11.6B | ||
| Q3 25 | $12.2B | $11.4B | ||
| Q2 25 | $12.2B | $11.4B | ||
| Q1 25 | $11.9B | $11.3B | ||
| Q4 24 | $11.8B | $6.0B | ||
| Q3 24 | $11.0B | $4.6B | ||
| Q2 24 | $10.9B | $4.6B |
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | 1.47× | ||
| Q3 25 | 0.53× | 1.51× | ||
| Q2 25 | 0.55× | 1.69× | ||
| Q1 25 | 0.56× | 1.79× | ||
| Q4 24 | 0.57× | 6.69× | ||
| Q3 24 | 0.36× | 3.95× | ||
| Q2 24 | 0.34× | 5.92× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | $99.4M |
| Free Cash FlowOCF − Capex | $175.0M | $41.1M |
| FCF MarginFCF / Revenue | 9.7% | 2.2% |
| Capex IntensityCapex / Revenue | 5.2% | 3.1% |
| Cash ConversionOCF / Net Profit | 0.88× | 0.71× |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | $633.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $99.4M | ||
| Q3 25 | $362.0M | $408.2M | ||
| Q2 25 | $221.0M | $186.1M | ||
| Q1 25 | $431.0M | $106.4M | ||
| Q4 24 | $481.0M | $129.1M | ||
| Q3 24 | $452.0M | $256.6M | ||
| Q2 24 | $333.0M | $150.6M |
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $41.1M | ||
| Q3 25 | $259.0M | $360.3M | ||
| Q2 25 | $107.0M | $149.4M | ||
| Q1 25 | $334.0M | $82.4M | ||
| Q4 24 | $388.0M | $108.2M | ||
| Q3 24 | $360.0M | $240.2M | ||
| Q2 24 | $230.0M | $122.1M |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | 2.2% | ||
| Q3 25 | 14.9% | 17.0% | ||
| Q2 25 | 6.4% | 7.9% | ||
| Q1 25 | 19.9% | 5.1% | ||
| Q4 24 | 22.8% | 9.0% | ||
| Q3 24 | 22.8% | 18.5% | ||
| Q2 24 | 14.6% | 9.9% |
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 3.1% | ||
| Q3 25 | 5.9% | 2.3% | ||
| Q2 25 | 6.8% | 2.0% | ||
| Q1 25 | 5.8% | 1.5% | ||
| Q4 24 | 5.5% | 1.7% | ||
| Q3 24 | 5.8% | 1.3% | ||
| Q2 24 | 6.5% | 2.3% |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | 0.71× | ||
| Q3 25 | 1.08× | 2.30× | ||
| Q2 25 | 1.03× | 1.88× | ||
| Q1 25 | 1.36× | — | ||
| Q4 24 | 1.37× | 1.80× | ||
| Q3 24 | 1.60× | 1.97× | ||
| Q2 24 | 1.08× | 1.42× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
SGI
| Mattress Firm Segment | $892.1M | 48% |
| Tempur Sealy North America Segment | $620.5M | 33% |
| Tempur Sealy International Segment | $355.8M | 19% |
